Achyut Healthcare
Achyut Healthcare (ACHYUT) share price was ₹8.04 at the 28 Oct 2026 close; market capitalisation ₹194 Cr; P/E (TTM) 402.00; sector Healthcare. The share price rose 38.1% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 1.3% year on year to ₹3.13 Cr and net profit was ₹0.14 Cr, against ₹0.10 Cr a year earlier (compared with Jun 2025). Promoters held 47.40% of Achyut Healthcare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,766.10 | 35.03 | 4,23,747 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,625.00 | 87.36 | 2,55,514 Cr | 15.24 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,595.50 | 72.14 | 1,74,798 Cr | 9.51 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,183.00 | 107.86 | 1,17,950 Cr | 22.26 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,179.50 | 26.25 | 1,17,656 Cr | 4.34 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,340.80 | 34.73 | 1,11,914 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,370.60 | 32.84 | 1,10,725 Cr | 3.13 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Achyut Healthcare (this company) | — | 402.00 | 194 Cr | 5.51 | 0.00% | 0.90% | 1.13% | 11 Cr | 0 Cr |
| Median 8 companies | ₹1,766.10 | 53.59 | 1,17,803 Cr | 5.29 | 0.47% | 12.98% | 16.41% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 98/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Debtor days have improved from 76.8 to 45.7 days.
- Company's working capital requirements have reduced from 515 days to 91.0 days
Weaknesses
4- Stock is trading at 3.95 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.53% over last 3 years.
- Promoter holding has decreased over last 3 years: -6.37%
Technical Indicators
Oscillators
Bearish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 5.75% · Jun 2026
Quarterly Results
| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 0.92 | 3.09 | 2.55 | 1.57 | 4.39 | 3.13 |
| Expenses | 0.13 | 0.87 | 3.02 | 2.47 | 1.58 | 4.37 | 2.95 |
| Operating Profit | -0.13 | 0.05 | 0.07 | 0.08 | -0.01 | 0.02 | 0.18 |
| OPM % | — | 5.43% | 2.27% | 3.14% | -0.64% | 0.46% | 5.75% |
| Other Income | 0.18 | 0.18 | 0.08 | 0.11 | 0.04 | 0.14 | 0.05 |
| Interest | 0 | 0.04 | 0.01 | 0 | 0 | 0.03 | 0.01 |
| Depreciation | 0 | 0.06 | 0.03 | 0.03 | 0.03 | 0.08 | 0.03 |
| PBT | 0.05 | 0.13 | 0.11 | 0.16 | 0 | 0.05 | 0.19 |
| Tax % | 20% | 7.69% | 9.09% | 31.25% | — | 0% | 26.32% |
| Net Profit | 0.03 | 0.12 | 0.1 | 0.12 | 0 | 0.06 | 0.14 |
| EPS (₹) | 0 | 0.01 | 0 | 0.01 | 0 | 0 | 0.01 |
Profit & Loss
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.67 | 0.33 | 0.27 | 4.05 | 2.7 | 6.14 | 3.05 | 11.59 | 11.64 |
| Expenses | 0.66 | 0.32 | 0.26 | 4.08 | 2.97 | 6.12 | 3.2 | 11.42 | 11.37 |
| Operating Profit | 0.01 | 0.01 | 0.01 | -0.03 | -0.27 | 0.02 | -0.15 | 0.17 | 0.27 |
| OPM % | 1.49% | 3.03% | 3.7% | -0.74% | -10% | 0.33% | -4.92% | 1.47% | 2.32% |
| Other Income | 0 | 0.01 | 0 | 0.14 | 0.59 | 0.73 | 0.92 | 0.38 | 0.34 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.04 |
| Depreciation | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.08 | 0.14 | 0.17 |
| PBT | 0.01 | 0.02 | 0.01 | 0.1 | 0.31 | 0.74 | 0.65 | 0.37 | 0.4 |
| Tax % | 300% | 0% | 0% | 60% | 25.81% | 32.43% | 21.54% | 16.22% | — |
| Net Profit | -0.01 | 0.01 | 0.01 | 0.04 | 0.23 | 0.5 | 0.51 | 0.32 | 0.32 |
| EPS (₹) | -0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 0.25 | 6.74 | 9.35 | 16.83 | 23.56 | 24.14 |
| Reserves | -0.05 | -0.04 | 0 | 2.34 | 5.18 | 13.93 | 7.71 | 10.93 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 1.55 | 1.49 |
| Other Liabilities | 0.04 | 0.06 | 0.25 | 0.86 | 0.81 | 0.19 | 1.3 | 1.54 |
| Total Liabilities | 0.24 | 0.27 | 0.5 | 9.94 | 15.34 | 30.95 | 34.12 | 38.1 |
| Fixed Assets | 0 | 0 | 0 | 0.03 | 0.05 | 0.06 | 1.44 | 1.55 |
| CWIP | 0 | 0 | 0 | 0 | 3.49 | 9.16 | 18.29 | 27.88 |
| Investments | 0 | 0 | 0 | 1.7 | 1.3 | 0 | 0 | 0 |
| Other Assets | 0.24 | 0.27 | 0.5 | 8.21 | 10.5 | 21.73 | 14.39 | 8.67 |
| Total Assets | 0.24 | 0.27 | 0.5 | 9.94 | 15.34 | 30.95 | 34.12 | 38.1 |
Cash Flow
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | -0.03 | -0.02 | 0.01 | -6.96 | -0.43 | -0.36 | -4 | 1.13 |
| Investing | 0 | 0 | 0 | -1.6 | -4.81 | -15.23 | -1.5 | -2.23 |
| Financing | 0 | 0 | 0 | 8.79 | 5.21 | 15.72 | -0.14 | 3.38 |
| Net Cash Flow | -0.03 | -0.02 | 0.01 | 0.24 | -0.03 | 0.14 | -5.64 | 2.29 |
| Free Cash Flow | -0.03 | -0.02 | 0.01 | -6.99 | -3.75 | -6.37 | -14.79 | -7.15 |
| CFO/EBITDA | -300 | -100 | 100 | 23,100 | 126 | -700 | 2,553 | 712 |
Ratios
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.48 | 188 | 379 | 18.02 | 36.5 | 24.37 | 160 | 45.66 |
| Inventory Days | 0 | 0 | 159 | 14.29 | 59.59 | 3.96 | 24.16 | 15.79 |
| Days Payable | — | — | 381 | 41.78 | 55.87 | 12.54 | 145 | 44.43 |
| Cash Conversion Cycle | 54.48 | 188 | 156 | -9.46 | 40.22 | 15.79 | 39.54 | 17.02 |
| Working Capital Days | 76.27 | 210 | 216 | 604 | 1,257 | 1,242 | 211 | 91.01 |
| ROCE % | — | 9.76% | 4.35% | 2.14% | 2.63% | 3.27% | 2.17% | 1.18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Achyut Healthcare insights
55 extracted metrics + investor summaries across FY19–FY27.
Documents
Frequently Asked Questions about Achyut Healthcare
What does Achyut Healthcare Ltd do?
Where is Achyut Healthcare Ltd (ACHYUT) listed?
Which sector does Achyut Healthcare Ltd belong to?
What is the market capitalisation of Achyut Healthcare Ltd?
What is the PE ratio of Achyut Healthcare Ltd?
What is the 52-week high and low of Achyut Healthcare Ltd?
What is the Return on Equity (ROE) of Achyut Healthcare Ltd?
Company Information
Achyut Healthcare Ltd (formerly Achyut Healthcare Pvt Ltd; originally Achyut Securities Pvt Ltd) is an Ahmedabad-based trader in APIs, pharmaceutical products/inputs and medical devices. It is developing a formulations plant at Bhat, Ahmedabad.[1][2]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543499.md for Achyut Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.